Updates from a Phase I clinical trial examining ublituximab in combination with TGR-1202
The potential clinical implications of targeted therapies for DLBCL and why the situation is complex
How to treat Richter’s transformation
The multi-cohort SCHOLAR-1 study of refractory aggressive DLBCL
Panel discussion on the treatment of adolescent and young adult lymphoma patients
Catherine Bollard et al.